Embed

Academic

Authors

Qingmei Weng

Qingmei Weng,Wadsworth Center,Microbiology,Virology,Pharmacology

Edit

Qingmei Weng

Wadsworth Center

Publications: 11 | Citations: 52

Fields: Microbiology, Virology, Pharmacology

Collaborated with 27 co-authors from 2002 to 2010 | Cited by 234 authors

Cumulative Annual

Sort by:

Publications (11)

BibTeX | RIS | RefWorks Download

Rapid quantification of single-nucleotide mutations in mixed influenza A viral populations using allele-specific mixture analysis (Citations: 6)

, , , , , , , ,

Journal: Journal of Virological Methods - J VIROL METH , vol. 163, no. 1, pp. 109-115, 2010

In Vitro System for Modeling Influenza A Virus Resistance under Drug Pressure (Citations: 1)

, , , , , , , ,

Journal: Antimicrobial Agents and Chemotherapy - ANTIMICROB AGENTS CHEMOTHER , vol. 54, no. 8, pp. 3442-3450, 2010

Prediction of the Pharmacodynamically Linked Variable of Oseltamivir Carboxylate for Influenza A Virus Using an In Vitro Hollow-Fiber Infection Model System (Citations: 4)

, , , ,

Journal: Antimicrobial Agents and Chemotherapy - ANTIMICROB AGENTS CHEMOTHER , vol. 53, no. 6, pp. 2375-2381, 2009

Pharmacodynamics of Cidofovir for Vaccinia Virus Infection in an In Vitro Hollow-Fiber Infection Model System (Citations: 2)

, , , ,

Journal: Antimicrobial Agents and Chemotherapy - ANTIMICROB AGENTS CHEMOTHER , vol. 53, no. 1, pp. 129-135, 2009

Use of AX4 Cells for the Study of the Pharmacodynamics of Oseltamivir Carboxylate for Influenza Viruses in an In Vitro Hollow Fiber Infection Model System

, , ,

Journal: Antiviral Research - ANTIVIR RES , vol. 78, no. 2, pp. A44-A45, 2008

Sort by:

Citations (52 times by 48 publications)

Construction of BIBAC and BAC libraries from a variety of organisms for advanced genomics research

, , , , , ,

Journal: Nature Protocols - NAT PROTOC , vol. 7, no. 3, pp. 479-499, 2012

Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant

, , , , , , , , , , , http://academic.research.microsoft.com/io.ashx?type=5&id=52330730&selfId1=6330403&selfId2=0&maxNumber=12&query=

Journal: PLOS One , vol. 6, no. 3, 2011

Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus

, , , , , , , ,

Journal: PLOS One , vol. 6, no. 12, 2011

Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus (Citations: 4)

, ,

Journal: Journal of Clinical Virology - J CLIN VIROL , vol. 49, no. 1, pp. 21-25, 2010

Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS8958, in Healthy Male Volunteers (Citations: 4)

, , ,

Journal: Journal of Clinical Pharmacology - J CLIN PHARMACOL , vol. 50, no. 11, pp. 1319-1329, 2010

Comments

Co-authors (27)

Journals (7)

Keywords (53)

Qingmei Weng,Wadsworth Center,Microbiology,Virology,Pharmacology

Publications (11)

BibTeX | RIS | RefWorks Download

Rapid quantification of single-nucleotide mutations in mixed influenza A viral populations using allele-specific mixture analysis (Citations: 6)

In Vitro System for Modeling Influenza A Virus Resistance under Drug Pressure (Citations: 1)

Prediction of the Pharmacodynamically Linked Variable of Oseltamivir Carboxylate for Influenza A Virus Using an In Vitro Hollow-Fiber Infection Model System (Citations: 4)

Pharmacodynamics of Cidofovir for Vaccinia Virus Infection in an In Vitro Hollow-Fiber Infection Model System (Citations: 2)

Use of AX4 Cells for the Study of the Pharmacodynamics of Oseltamivir Carboxylate for Influenza Viruses in an In Vitro Hollow Fiber Infection Model System

Citations (52 times by 48 publications)

Construction of BIBAC and BAC libraries from a variety of organisms for advanced genomics research

Genomic Signatures of Strain Selection and Enhancement in Bacillus atrophaeus var. globigii, a Historical Biowarfare Simulant

Triple Combination Antiviral Drug (TCAD) Composed of Amantadine, Oseltamivir, and Ribavirin Impedes the Selection of Drug-Resistant Influenza A Virus

Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus (Citations: 4)

Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS8958, in Healthy Male Volunteers (Citations: 4)


	View FAQ about top research areas and Fields of study

Qingmei Weng,Wadsworth Center,Microbiology,Virology,Pharmacology

Publications (11) BibTeX | RIS | RefWorks Download

Rapid quantification of single-nucleotide mutations in mixed influenza A viral populations using allele-specific mixture analysis (Citations: 6)

In Vitro System for Modeling Influenza A Virus Resistance under Drug Pressure (Citations: 1)

Prediction of the Pharmacodynamically Linked Variable of Oseltamivir Carboxylate for Influenza A Virus Using an In Vitro Hollow-Fiber Infection Model System (Citations: 4)

Pharmacodynamics of Cidofovir for Vaccinia Virus Infection in an In Vitro Hollow-Fiber Infection Model System (Citations: 2)

Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A/H1N1 virus (Citations: 4)

Clinical Pharmacokinetics of Laninamivir, a Novel Long-Acting Neuraminidase Inhibitor, After Single and Multiple Inhaled Doses of Its Prodrug, CS8958, in Healthy Male Volunteers (Citations: 4)

Publications (11)

BibTeX | RIS | RefWorks Download